In conclusion, a thorough investigation of lipid metabolism-related genes was conducted for patients with breast cancer, and a prognostic signature encompassing two biomarkers (FABP7 and NDUFAB1) was discovered for the application of immunotherapy. The gene discussed is FABP7; the disease is breast cancer.